Analyst Research

Report Title Price
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Stueve Siegel Hanson and Gray Ritter & Graham Announces Vioxx Consumer Fraud Class Action Settlement Against Merck & Co Inc


Thursday, 1 Nov 2012 06:38pm EDT 

Stueve Siegel Hanson LLP and Gray Ritter & Graham announced that they have reached a settlement in the only certified consumer fraud class action lawsuit with Merck & Co. Inc. regarding Vioxx, the Company's prescription pain reliever used for the treatment of certain arthritis conditions. The class action lawsuit involved claims alleging that Merck's promotion and sale of Vioxx constituted unlawful and unfair business practices under the Missouri Merchandising Practices Act. Under the settlement terms, qualifying Missouri consumers of Vioxx may be reimbursed in full for their Vioxx purchases. The common fund settlement provides for payment to class members under two options a one-time cash payment of $180 to Settlement Class Members who submit a valid claim form with a declaration under oath (but no documentary proof of payment required) and $90 for each month of Vioxx purchases supported by a declaration under oath with documentary proof of payment, such as a letter from the prescribing physician. In addition to paying the claims of qualifying class members, the settlement requires Merck to pay for all costs associated with the notice and administration of the settlement as well as court-approved attorneys` fees and expenses incurred by the Class. 

Company Quote

59.48
0.57 +0.97%
4:01pm EDT